David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 27,514 shares at $11.11 ($306K) on 2019-03-11, disclosed to the SEC on 2019-03-15.
Seasonal sale ($306k) by Chief Accounting Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.11 | 13,492 | $150K | 49.0% |
| 2 | $11.11 | 13,492 | $150K | 49.0% |
| 3 | $11.05 | 530 | $6K | 1.9% |
| Total | $11.11 avg | 27,514 | $306K | 100% |
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |